Earnings call briefThird-quarter 2026
Intuitive Surgical says price cuts will lower I&A revenue per procedure
Intuitive Surgical expects the reduction to be approximately 3% to 5% on a mix-constant basis once fully implemented.
GetSignal Intuitive Surgical ISRG
CFO Jamie Samath said on the third-quarter call that the company will begin pricing actions in the first half of 2027, including an expanded extended use program. Samath said the company expects a modest gross margin impact in 2027, to be offset by cost reduction programs. Samath said that is less than the 7% the company estimated when it launched its first extended use program in 2020.
Quotes from the call
“Today, we are also quantifying the instrument pricing actions we discussed in July, which we expect to reduce da Vinci I&A revenue per procedure by approximately 3% to 5% on a mix-constant basis once fully implemented.”
Key facts from the call
- Expected da Vinci instrument revenue per procedure reduction
- Approximately 3% to 5% on a mix-constant basis once fully implemented
- Expected start of pricing actions
- First half of 2027, rolling out country by country
- Expected China price reduction start
- November
Source: Intuitive Surgical's third-quarter 2026 earnings call, October 20, 2026.
Written by GetSignal with AI from the company's earnings call.
Not investment advice.
More earnings call briefs
- Constellation Energy expects nuclear uprate costs of about $4.3 billion
CEG Constellation Energy Q3 2026 call
- Howard Hughes Holdings says its insurance ambition is a return on equity in excess of 20%
HHH Howard Hughes Holdings Q3 2026 call
- Brookfield Asset Management now sees 2026 earnings modestly below early view
BAM Brookfield Asset Management Q3 2026 call
- Enbridge says it expects 2026 results at the midpoint of its guidance range
ENB Enbridge Q3 2026 call
- TeraWulf sees about half of contracted IT capacity earning revenue by end of Q1
WULF TeraWulf Q3 2026 call
